{"entity":{"type":"insider","cik":"0001498428","url":"/insider/0001498428","json_url":"/insider/0001498428.json","name":"Cox John","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":37,"n_filings":25,"first":"2010-10-29","last":"2026-08-17","span_basis":"filed_date"},"name_variants":[{"name":"Cox John","source":"filing","n_filings":25,"first_seen":"2010-10-29","last_seen":"2026-08-17"}],"transactions":[{"id":9290579,"accession":"0001498428-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001498428-26-000004","line_url":"/filing/0001498428-26-000004#line-1","is_derivative":false,"issuer_cik":"0001498428","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001498428","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4986.0,"shares_display":"4,986","price_per_share":26.28,"price_display":"26.28","price_state":"stated","total_value":131032.08,"total_display":"131,032.08","total_whole":"131,032","shares_owned_after":363165.0,"shares_owned_after_display":"363,165","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-13","filed_date":"2026-08-17","scope":"insider"},{"id":5844756,"accession":"0001498428-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001498428-26-000002","line_url":"/filing/0001498428-26-000002#line-1","is_derivative":false,"issuer_cik":"0001498428","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001498428","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2683.0,"shares_display":"2,683","price_per_share":18.33,"price_display":"18.33","price_state":"stated","total_value":49179.39,"total_display":"49,179.39","total_whole":"49,179","shares_owned_after":368151.0,"shares_owned_after_display":"368,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-16","filed_date":"2026-06-17","scope":"insider"},{"id":5944065,"accession":"0001193125-26-223955","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-223955","line_url":"/filing/0001193125-26-223955#line-1","is_derivative":false,"issuer_cik":"0001498428","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001498428","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3311.0,"shares_display":"3,311","price_per_share":18.36,"price_display":"18.36","price_state":"stated","total_value":60789.96,"total_display":"60,789.96","total_whole":"60,790","shares_owned_after":370834.0,"shares_owned_after_display":"370,834","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-13","filed_date":"2026-05-14","scope":"insider"},{"id":6171681,"accession":"0001193125-26-096512","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-096512","line_url":"/filing/0001193125-26-096512#line-1","is_derivative":false,"issuer_cik":"0001498428","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001498428","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2732.0,"shares_display":"2,732","price_per_share":14.9,"price_display":"14.90","price_state":"stated","total_value":40706.8,"total_display":"40,706.80","total_whole":"40,707","shares_owned_after":374145.0,"shares_owned_after_display":"374,145","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-05","filed_date":"2026-03-06","scope":"insider"},{"id":4624203,"accession":"0001193125-25-309666","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-309666","line_url":"/filing/0001193125-25-309666#line-1","is_derivative":false,"issuer_cik":"0001498428","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001498428","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2662.0,"shares_display":"2,662","price_per_share":20.72,"price_display":"20.72","price_state":"stated","total_value":55156.64,"total_display":"55,156.64","total_whole":"55,157","shares_owned_after":196877.0,"shares_owned_after_display":"196,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-05","filed_date":"2025-12-05","scope":"insider"},{"id":4040765,"accession":"0001498428-25-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001498428-25-000003","line_url":"/filing/0001498428-25-000003#line-1","is_derivative":false,"issuer_cik":"0001498428","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001498428","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2640.0,"shares_display":"2,640","price_per_share":13.41,"price_display":"13.41","price_state":"stated","total_value":35402.4,"total_display":"35,402.40","total_whole":"35,402","shares_owned_after":199539.0,"shares_owned_after_display":"199,539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-05","filed_date":"2025-09-09","scope":"insider"},{"id":4792848,"accession":"0000950170-25-095929","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-095929","line_url":"/filing/0000950170-25-095929#line-1","is_derivative":false,"issuer_cik":"0001498428","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001498428","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":9.11,"price_display":"9.11","price_state":"stated","total_value":911000.0,"total_display":"911,000.00","total_whole":"911,000","shares_owned_after":242179.0,"shares_owned_after_display":"242,179","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-14","filed_date":"2025-07-15","scope":"insider"},{"id":4418395,"accession":"0000950170-25-083071","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-083071","line_url":"/filing/0000950170-25-083071#line-1","is_derivative":false,"issuer_cik":"0001498428","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001498428","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4060.0,"shares_display":"4,060","price_per_share":13.35,"price_display":"13.35","price_state":"stated","total_value":54201.0,"total_display":"54,201.00","total_whole":"54,201","shares_owned_after":142179.0,"shares_owned_after_display":"142,179","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-05","filed_date":"2025-06-06","scope":"insider"},{"id":4660297,"accession":"0000950170-25-035495","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-035495","line_url":"/filing/0000950170-25-035495#line-1","is_derivative":false,"issuer_cik":"0001498428","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001498428","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4061.0,"shares_display":"4,061","price_per_share":11.83,"price_display":"11.83","price_state":"stated","total_value":48041.63,"total_display":"48,041.63","total_whole":"48,042","shares_owned_after":146239.0,"shares_owned_after_display":"146,239","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-07","scope":"insider"},{"id":2177769,"accession":"0000950170-24-103533","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000950170-24-103533","line_url":"/filing/0000950170-24-103533","is_derivative":false,"issuer_cik":"0001498428","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001498428","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":32000.0,"shares_display":"32,000","price_per_share":33.038,"price_display":"33.04","price_state":"stated","total_value":1057216.0,"total_display":"1,057,216.00","total_whole":"1,057,216","shares_owned_after":8000.0,"shares_owned_after_display":"8,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-04","filed_date":"2024-09-04","scope":"insider","n_lines":8},{"id":3161054,"accession":"0000899243-20-009592","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-009592","line_url":"/filing/0000899243-20-009592#line-1","is_derivative":false,"issuer_cik":"0000730272","issuer_name":"REPLIGEN CORP","issuer_ticker":"RGEN","issuer_name_source":null,"issuer_url":"/issuer/0000730272","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1858.0,"shares_display":"1,858","price_per_share":96.72,"price_display":"96.72","price_state":"stated","total_value":179705.76,"total_display":"179,705.76","total_whole":"179,706","shares_owned_after":923.0,"shares_owned_after_display":"923","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-24","filed_date":"2020-03-26","scope":"insider"},{"id":3161020,"accession":"0000899243-20-009121","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-20-009121","line_url":"/filing/0000899243-20-009121","is_derivative":false,"issuer_cik":"0000730272","issuer_name":"REPLIGEN CORP","issuer_ticker":"RGEN","issuer_name_source":null,"issuer_url":"/issuer/0000730272","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26736.0,"shares_display":"26,736","price_per_share":95.26612657091562,"price_display":"95.27","price_state":"stated","total_value":2547035.16,"total_display":"2,547,035.16","total_whole":"2,547,035","shares_owned_after":4984.0,"shares_owned_after_display":"4,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-18","filed_date":"2020-03-20","scope":"insider","n_lines":3},{"id":2541281,"accession":"0000899243-20-007240","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-007240","line_url":"/filing/0000899243-20-007240#line-2","is_derivative":false,"issuer_cik":"0000730272","issuer_name":"REPLIGEN CORP","issuer_ticker":"RGEN","issuer_name_source":null,"issuer_url":"/issuer/0000730272","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":93.39,"price_display":"93.39","price_state":"stated","total_value":933900.0,"total_display":"933,900.00","total_whole":"933,900","shares_owned_after":2781.0,"shares_owned_after_display":"2,781","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-04","filed_date":"2020-03-05","scope":"insider"},{"id":2631591,"accession":"0000899243-20-005905","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-005905","line_url":"/filing/0000899243-20-005905","is_derivative":false,"issuer_cik":"0000730272","issuer_name":"REPLIGEN CORP","issuer_ticker":"RGEN","issuer_name_source":null,"issuer_url":"/issuer/0000730272","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4455.0,"shares_display":"4,455","price_per_share":92.80691358024691,"price_display":"92.81","price_state":"stated","total_value":413454.8,"total_display":"413,454.80","total_whole":"413,455","shares_owned_after":2781.0,"shares_owned_after_display":"2,781","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-24","filed_date":"2020-02-26","scope":"insider","n_lines":2},{"id":8091994,"accession":"0001127602-15-012652","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-15-012652","line_url":"/filing/0001127602-15-012652#line-3","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Officer (EVP Pharmaceutical Oper & Tech)","role_mark":"O","role_mark_label":"Officer (EVP Pharmaceutical Oper & Tech)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Pharmaceutical Oper & Tech","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12010.0,"shares_display":"12,010","price_per_share":449.06,"price_display":"449.06","price_state":"stated","total_value":5393210.6,"total_display":"5,393,210.60","total_whole":"5,393,211","shares_owned_after":25567.2925,"shares_owned_after_display":"25,567.29","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-25","filed_date":"2015-03-26","scope":"insider"},{"id":9129047,"accession":"0001127602-11-028521","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-11-028521","line_url":"/filing/0001127602-11-028521#line-2","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Officer (EVP Pharmaceutical Oper & Tech)","role_mark":"O","role_mark_label":"Officer (EVP Pharmaceutical Oper & Tech)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Pharmaceutical Oper & Tech","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2175.0,"shares_display":"2,175","price_per_share":114.37,"price_display":"114.37","price_state":"stated","total_value":248754.75,"total_display":"248,754.75","total_whole":"248,755","shares_owned_after":9588.0295,"shares_owned_after_display":"9,588.03","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-01","filed_date":"2011-11-03","scope":"insider"},{"id":9138488,"accession":"0001127602-11-013555","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-11-013555","line_url":"/filing/0001127602-11-013555#line-2","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Officer (EVP Pharmaceutical Oper & Tech)","role_mark":"O","role_mark_label":"Officer (EVP Pharmaceutical Oper & Tech)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Pharmaceutical Oper & Tech","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4350.0,"shares_display":"4,350","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":435000.0,"total_display":"435,000.00","total_whole":"435,000","shares_owned_after":10353.0295,"shares_owned_after_display":"10,353.03","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-21","filed_date":"2011-04-25","scope":"insider"},{"id":9149795,"accession":"0001127602-11-013035","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-11-013035","line_url":"/filing/0001127602-11-013035#line-5","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Officer (EVP Pharmaceutical Oper & Tech)","role_mark":"O","role_mark_label":"Officer (EVP Pharmaceutical Oper & Tech)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Pharmaceutical Oper & Tech","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36234.0,"shares_display":"36,234","price_per_share":80.0,"price_display":"80.00","price_state":"stated","total_value":2898720.0,"total_display":"2,898,720.00","total_whole":"2,898,720","shares_owned_after":10353.0295,"shares_owned_after_display":"10,353.03","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-13","filed_date":"2011-04-15","scope":"insider"},{"id":8828328,"accession":"0001127602-11-012908","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-11-012908","line_url":"/filing/0001127602-11-012908#line-2","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Officer (EVP Pharmaceutical Oper & Tech)","role_mark":"O","role_mark_label":"Officer (EVP Pharmaceutical Oper & Tech)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Pharmaceutical Oper & Tech","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6900.0,"shares_display":"6,900","price_per_share":78.0,"price_display":"78.00","price_state":"stated","total_value":538200.0,"total_display":"538,200.00","total_whole":"538,200","shares_owned_after":10353.0295,"shares_owned_after_display":"10,353.03","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-11","filed_date":"2011-04-13","scope":"insider"},{"id":9005942,"accession":"0001127602-11-011607","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-11-011607","line_url":"/filing/0001127602-11-011607#line-2","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Officer (EVP Pharmaceutical Oper & Tech)","role_mark":"O","role_mark_label":"Officer (EVP Pharmaceutical Oper & Tech)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Pharmaceutical Oper & Tech","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2840.0,"shares_display":"2,840","price_per_share":73.0,"price_display":"73.00","price_state":"stated","total_value":207320.0,"total_display":"207,320.00","total_whole":"207,320","shares_owned_after":9818.0411,"shares_owned_after_display":"9,818.04","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-31","filed_date":"2011-04-01","scope":"insider"},{"id":9118553,"accession":"0001127602-11-008674","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-11-008674","line_url":"/filing/0001127602-11-008674","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Officer (EVP Pharmaceutical Oper & Tech)","role_mark":"O","role_mark_label":"Officer (EVP Pharmaceutical Oper & Tech)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Pharmaceutical Oper & Tech","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4041.0,"shares_display":"4,041","price_per_share":70.09616599851522,"price_display":"70.10","price_state":"stated","total_value":283258.6068,"total_display":"283,258.61","total_whole":"283,259","shares_owned_after":9918.0411,"shares_owned_after_display":"9,918.04","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-02","filed_date":"2011-03-03","scope":"insider","n_lines":3},{"id":9011648,"accession":"0001127602-11-006362","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-11-006362","line_url":"/filing/0001127602-11-006362#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Officer (EVP Pharmaceutical Oper & Tech)","role_mark":"O","role_mark_label":"Officer (EVP Pharmaceutical Oper & Tech)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Pharmaceutical Oper & Tech","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1843.0,"shares_display":"1,843","price_per_share":67.0752,"price_display":"67.08","price_state":"stated","total_value":123619.5936,"total_display":"123,619.59","total_whole":"123,620","shares_owned_after":13603.0411,"shares_owned_after_display":"13,603.04","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-17","filed_date":"2011-02-18","scope":"insider"},{"id":7482135,"accession":"0001127602-10-027651","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-10-027651","line_url":"/filing/0001127602-10-027651#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Officer (EVP Pharmaceutical Oper & Tech)","role_mark":"O","role_mark_label":"Officer (EVP Pharmaceutical Oper & Tech)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Pharmaceutical Oper & Tech","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":773.0,"shares_display":"773","price_per_share":62.868,"price_display":"62.87","price_state":"stated","total_value":48596.964,"total_display":"48,596.96","total_whole":"48,597","shares_owned_after":16356.0411,"shares_owned_after_display":"16,356.04","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-09","filed_date":"2010-11-10","scope":"insider"},{"id":7755471,"accession":"0001127602-10-026742","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-10-026742","line_url":"/filing/0001127602-10-026742#line-2","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Officer (EVP Pharmaceutical Oper & Tech)","role_mark":"O","role_mark_label":"Officer (EVP Pharmaceutical Oper & Tech)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Pharmaceutical Oper & Tech","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":765.0,"shares_display":"765","price_per_share":63.0426,"price_display":"63.04","price_state":"stated","total_value":48227.589,"total_display":"48,227.59","total_whole":"48,228","shares_owned_after":17129.0411,"shares_owned_after_display":"17,129.04","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-02","filed_date":"2010-11-03","scope":"insider"},{"id":7362195,"accession":"0001127602-10-026174","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-10-026174","line_url":"/filing/0001127602-10-026174#line-2","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001498428","owner_name":"Cox John","owner_display_name":"Cox John","owner_url":"/insider/0001498428","role":"Officer (EVP Pharmaceutical Oper & Tech)","role_mark":"O","role_mark_label":"Officer (EVP Pharmaceutical Oper & Tech)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Pharmaceutical Oper & Tech","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6900.0,"shares_display":"6,900","price_per_share":63.0,"price_display":"63.00","price_state":"stated","total_value":434700.0,"total_display":"434,700.00","total_whole":"434,700","shares_owned_after":18254.0411,"shares_owned_after_display":"18,254.04","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-10-28","filed_date":"2010-10-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":37,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":9,"open_market":true},{"code":"S","label":"Open-market sale","n":28,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":37},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001818794","name":"Dyne Therapeutics, Inc.","url":"/issuer/0001818794","role":"Director, Officer (CEO & President)","n_filings":10,"first_seen":"2024-09-04","last_seen":"2026-08-17"},{"type":"issuer","type_label":"ISSUER","cik":"0000730272","name":"REPLIGEN CORP","url":"/issuer/0000730272","role":"Director","n_filings":4,"first_seen":"2020-02-26","last_seen":"2020-03-26"},{"type":"issuer","type_label":"ISSUER","cik":"0000875045","name":"BIOGEN INC.","url":"/issuer/0000875045","role":"Officer (EVP Pharmaceutical Oper & Tech)","n_filings":11,"first_seen":"2010-10-29","last_seen":"2015-03-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001498428","retrieved_at":"2026-08-23T20:57:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}